Mark Murphy Fca

Mark Murphy is the VP of Finance at Beacon Therapeutics, with extensive experience in finance roles at various companies such as Novartis, Iroko Pharmaceuticals, and Shire Pharmaceuticals. Mark has managed financial functions, prepared financial statements, budgets, and forecasts, and ensured compliance with accounting principles. Mark also has experience in managing acquisitions, implementing new systems, and leading finance teams. Mark holds a CPA and ACA degree, along with a Master's degree in Accounting and a Bachelor's degree in Business Studies.